Groupe Hospitalier Diaconesses Croix Saint-Simon | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical Cancer	Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder	Not yet recruiting	Phase 2	2026-08-13		NCT07763496
Personalized Medicine for Advanced Biliary Cancer Patients	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasm	Recruiting	Phase 3	2026-05-19		NCT05615818
First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder	Recruiting	Phase 2	2025-09-22		NCT06253611
Materiovigilance After Urinary Incontinence or Prolapse Surgery	Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Prolapse, Signs and Symptoms, Urinary Incontinence, Urinary Incontinence, Stress, Urination Disorders, Urogenital Diseases, Urological Manifestations, digestive system disorder, intestinal disorder, pelvic organ prolapse, rectal disorder, rectal prolapse, urinary system disorder	Active, not recruiting	Not stated	2023-09-21		NCT03052985